Digirad Corporation announced that it has completed its previously announced strategic partnership and investment into Perma-Fix Medical S.A. Under this partnership, Digirad invested $1 million into Perma-Fix Medical S.A. The investment constituted approximately 5.4% of the outstanding common shares of Perma-Fix Medical S.A. As part of the partnership and investment, Digirad appointed Matt Molchan, President and CEO of Digirad Corporation, to Perma-Fix Medical S.A.'s Supervisory Board.